TWD
MAZE

True Wealth Design’s Maze Therapeutics MAZE Stock Holding History

True Wealth Design’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5
Closed -$150 – 2929
2026
Q1 		$150 Hold
5
– – ﹤0.01% 2388
2025
Q4 		$208 Hold
5
– – ﹤0.01% 2220
2025
Q3 		$130 Hold
5
– – ﹤0.01% 2404
2025
Q2 		$62 Buy
+5
New +$52 ﹤0.01% 2343

Other funds holding MAZE

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FWP
Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

True Wealth Design's MAZE Position: Q2 2026 in Review

True Wealth Design sold out of Maze Therapeutics (MAZE) in Q2 2026, closing a stake of 5 shares — an estimated $150 sold.

True Wealth Design first reported a position in MAZE in Q2 2025 and held it in 4 quarters. The position peaked at $208 in Q4 2025. 7 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • True Wealth Design reported no remaining Maze Therapeutics position as of Q2 2026 after selling out during the quarter.
  • True Wealth Design sold 5 Maze Therapeutics shares in Q2 2026, an estimated $150.
  • True Wealth Design first reported a position in Maze Therapeutics in Q2 2025 and held it in 4 quarters.
  • True Wealth Design's Maze Therapeutics position peaked at $208 in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.